Barclays’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,598
| Closed | -$5K | – | 7070 |
|
|
2016
Q3 | $5K | Sell |
1,598
-2,082
| -57% | -$3.61K | ﹤0.01% | 6047 |
|
|
2016
Q2 | $6K | Sell |
3,680
-2,527
| -41% | -$5.78K | ﹤0.01% | 5724 |
|
|
2016
Q1 | $18K | Sell |
6,207
-20,614
| -77% | -$128K | ﹤0.01% | 5279 |
|
|
2015
Q4 | $268K | Buy |
26,821
+17,491
| +187% | +$211K | ﹤0.01% | 3679 |
|
|
2015
Q3 | $122K | Buy |
9,330
+8,346
| +848% | +$149K | ﹤0.01% | 4485 |
|
|
2015
Q2 | $17K | Sell |
984
-25,490
| -96% | -$552K | ﹤0.01% | 5798 |
|
|
2015
Q1 | $688K | Sell |
26,474
-213,253
| -89% | -$5.43M | ﹤0.01% | 3301 |
|
|
2014
Q4 | $4.79M | Sell |
239,727
-93,632
| -28% | -$2.36M | ﹤0.01% | 1735 |
|
|
2014
Q3 | $11M | Sell |
333,359
-37,504
| -10% | -$1.16M | 0.01% | 1104 |
|
|
2014
Q2 | $11.9M | Buy |
370,863
+118,556
| +47% | +$4.41M | 0.01% | 1026 |
|
|
2014
Q1 | $11.6M | Sell |
252,307
-10,674
| -4% | -$626K | 0.01% | 1042 |
|
|
2013
Q4 | $18.4M | Buy |
262,981
+48,367
| +23% | +$3.7M | 0.02% | 810 |
|
|
2013
Q3 | $18.2M | Buy |
214,614
+130,490
| +155% | +$11.1M | 0.02% | 725 |
|
|
2013
Q2 | $5.33M | Buy |
+84,124
| New | +$4.47M | 0.01% | 1573 |
|